Pharmaceutical Executive, May 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2022 issue in an interactive PDF format.
Articles in this issue
Restoring Hope in Mental Illness Is a Collective Mission
Data Vigilance and Validation: Lessons Learned, Future Hopes for Real-World Data
Upward Mobility: Optimizing Your Pharma T-Profile
Breadth, Depth, and Enterprise
Rising to the Task
Lessons Learned
Persistence Pays Off
Authenticity in Action
Challenging Assumptions
Steady at the Controls
The ‘Grit’ to Get It Done
Living the Translation
Fueled by Purpose
Same Mission, Altered Course
Pharmaceutical Executive's 2022 Emerging Pharma Leaders
Recent Videos
Related Content
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Podcast
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist
March 25th 2025Article
Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.
